MARKET

CELZ

CELZ

Creative Med Technology Hldgs
NASDAQ
1.930
+0.150
+8.43%
After Hours: 1.801 -0.129 -6.69% 16:43 02/06 EST
OPEN
1.860
PREV CLOSE
1.780
HIGH
1.980
LOW
1.800
VOLUME
37.49K
TURNOVER
--
52 WEEK HIGH
6.90
52 WEEK LOW
1.504
MARKET CAP
6.74M
P/E (TTM)
-0.6719
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CELZ last week (0126-0130)?
Weekly Report · 5d ago
Weekly Report: what happened at CELZ last week (0119-0123)?
Weekly Report · 01/26 10:09
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 01/20 12:05
Weekly Report: what happened at CELZ last week (0112-0116)?
Weekly Report · 01/19 10:15
Creative Medical's ADAPT Trial In Chronic Lower Back Pain Shows Functional And Pain Improvements
NASDAQ · 01/13 15:50
Creative Medical announces interim data from ADAPT trial of CELZ-201
TipRanks · 01/13 14:25
Creative Medical Announces Interim 180-Day Follow-Up Data From FDA-Cleared ADAPT Clinical Trial Evaluating CELZ-201, Proprietary Perinatal Tissue-Derived Cell Therapy For Chronic Lower Back Pain
Benzinga · 01/13 14:17
Creative Medical Technology Reports Positive Interim Results for CELZ-201 in Chronic Lower Back Pain Trial
Reuters · 01/13 14:15
More
About CELZ
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.

Webull offers Creative Medical Technology Holdings Inc stock information, including NASDAQ: CELZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CELZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CELZ stock methods without spending real money on the virtual paper trading platform.